Related Experiment Videos
Copper complexes with bioactive ligands. Part II--Antifungal activity
B Dudová1, D Hudecová, R Pokorný
1Department of Biochemistry and Microbiology, Faculty of Chemical and Food Technology, Slovak University of Technology, 812 37 Bratislava, Slovakia. dudova@chelin.chtf.stuba.sk
Folia Microbiologica
|July 4, 2002
Summary
New copper(II) complexes with bioactive ligands show significant antifungal activity against filamentous fungi like Rhizopus oryzae and Microsporum gypseum. These complexes effectively inhibit fungal growth and sporulation, offering potential for novel antifungal agents.
Area of Science:
- Inorganic Chemistry
- Mycology
- Medicinal Chemistry
Background:
- Copper(II) complexes are explored for their biological activities.
- Nicotinic acid derivatives and related amides are known for their bioactivity.
- Developing new antifungal agents is crucial due to increasing resistance.
Purpose of the Study:
- To synthesize and characterize new copper(II) complexes.
- To evaluate the in vitro antifungal activity of these complexes against various filamentous fungi.
- To investigate the structure-activity relationship of these complexes.
Main Methods:
- Synthesis and characterization of copper(II) complexes.
- Macrodilution method for determining antifungal activity.
- Microscopy to observe morphological changes in fungi.
Main Results:
- Copper(II) complexes with 2-methylthionicotinate and bioactive ligands (nicotinamide, N-methylnicotinamide, ethyl nicotinate) exhibited potent antifungal activity.
- Rhizopus oryzae and Microsporum gypseum were most sensitive (IC50 1.5-2.3 mmol/L).
- Morphological changes, including hyphal branching and inhibition of sporulation, were observed in Botrytis cinerea and Alternaria alternata.
Conclusions:
- The synthesized copper(II) complexes demonstrate significant antifungal potential.
- The presence of bioactive ligands enhances the antifungal efficacy of copper(II) complexes.
- These compounds represent promising candidates for the development of new antifungal therapies.